The Practice-Based Research Network (PBRN) SIG is shifting focus to be the Primary Care SIG.  They meet every other month on the fourth Monday at 9 am PT/noon ET.  Please spread the word that all interested people are welcome to join! The next meeting will be Monday, March 25. Dr. David Fiellin is presenting.  Here are the login details: Primary Care SIG webinar on March 25th from 9-10am PDT/12-1pm EDT TOPIC: “Are we there yet? 25 years of research on treating OUD in primary care.”  SPEAKER: David Fiellin, MD Professor of Medicine, Emergency Medicine and Public Health Vice Chief, Faculty Affairs, General Internal Medicine Director, Program in Addiction Medicine Yale School of Medicine  Please join the webinar here (no registration required):Passcode: 201068 Interested in presenting at a future Primary Care SIG meeting? Email Sebastian Tong at setong@uw.edu.

Join NIDA’s next HIV Research Program Seminar on April 17, 2024 at 10am PT, with our Avant-Garde Award recipient Dr. Schahram Akbarian, Professor of Psychiatric Epigenomics at Mount Sinai. Dr. Akbarian will present a talk on “Novel Neurogenomic Techniques to Explore #HIV in the Brain.” Dr. Akbarian’s laboratory explores the neurogenomics of HIV and drug use in human and mouse brains, including single-molecule and single-cell technologies.  Download flyer | Register here

The CTN Youth SIG is pleased to invite you to an upcoming presentation/webinar: The Power of Play: Using Digital Health Games to Target Adolescent Substance Use and Mental Health Presenter: Lynn Fiellin, M.D. Friday, March 15th, 2024 (11:00 a.m.–12:00 p.m. ET)Join Zoom MeetingMeeting ID: 977 1685 1154Passcode: 832521 This presentation will highlight the work of the play2PREVENT Lab, an academic games research program, and the use of serious videogame interventions to impact health outcomes, particularly substance use and mental health, in adolescents. This talk will outline the process and outcomes involved with the past 15 years of this NIH-funded research. About the presenter Dr. Lynn Fiellin is a Professor of Biomedical Data Science and the Center for Technology & Behavioral Health at Dartmouth College, Professor Adjunct at Yale, and the Founding Director of the play2PREVENT (p2P) Lab where she and her team focus on developing and evaluating digital health games. These games, as “serious videogames,” impact the health and well-being of adolescents, including opioid misuse, smoking/vaping, mental health, and sexual health. Most recently, she founded a new company, Playbl, that focuses on the broad-scale marketing and distribution of the 5 videogames developed and evaluated by the Lab. Upcoming Youth SIG Seminar Speakers in 2024 (all times are at 11am-12pm ET):May 17 – Dr. Kammarauche AneniSept 20 – Dr. Sivabalaji KaliamurthyNov 15 – Dr. Velma Murry

The National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) Practice-Based Research Network (PBRN) SIG is transitioning to a Primary Care SIG (revitalizing the PBRN into primary care focus). To launch this, the Primary Care SIG is hosting a webinar titled Primary Care Practice Engagement: The SPARC Trial to Increase Alcohol-Related Prevention and Treatment. This virtual meeting is scheduled for Monday, January 22, 2024 from 12:00 p.m.– 1:00 p.m. ET. Speaker: Kathy Bradley, M.D. (Health Systems Node) Description: Dr. Bradley will speak on her team’s experience engaging primary care clinics in the SPARC trial. SPARC used practice facilitation, EHR tools and performance feedback, to implement alcohol-related prevention and treatment across 25 primary care clinics: 3 pilot sites and 22 sites in a stepped wedge trial in which the implementation intervention increased alcohol screening, brief intervention, AUD diagnosis, and initiation of AUD treatment (but not treatment engagement). The trial has been described in multiple publications (main results Lee JAMA Internal Medicine 2023). This presentation will focus on overcoming challenges in implementing the intervention in primary care clinics. This meeting will be recorded. If you are interested, please join the webinar here (no registration required). Please contact Maria Prado pradom@uw.edu to be added to the calendar invite and for access to the meeting recording afterwards. If you have any questions about the meeting logistics, please contact CTNSupport@leedmci.com. If you have any questions about the webinar content, please contact Sebastian Tong setong@uw.edu. Individuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event should contact Sean Randol at (240) 863-0507 or srandol@leedmci.com or through…

The CTN Youth SIG is pleased to invite you to an upcoming presentation/webinar: Title: Unveiling Youth Perspectives on Fentanyl and the Adolescent Inpatient Addiction Treatment Landscape in the U.S.Presenters: Todd Korthuis, MD, MPH and Erin Stack, MSDate: Friday, January 19th, 2024 (11:00 a.m.–12:00 p.m. ET)Join Zoom Meeting: https://dartmouth.zoom.us/j/91937382102?pwd=OXJyK3NCOE1LaTZtQkVQUm42WlJhQT09Zoom Meeting ID: 919 3738 2102Passcode: 284403 Dr. Todd Korthuis is Professor of Medicine and Addiction Medicine Section Head at Oregon Health & Science University. He conducts addiction health services research and serves as Co-PI of the Western States Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) Ms. Erin Stack has 15 years of experience supporting and leading research and evaluation projects, with expertise in community-based approaches. Trained as a community psychologist, her research focuses on promoting community health, equity, and safety, and more recently on understanding the needs of people with substance use disorders. In their complimentary presentation, Ms. Stack will showcase descriptive results from the Oregon Youth and Young Adult Fentanyl Survey, conducted to understand youth and young adults’ knowledge, beliefs, and behaviors related to fentanyl and counterfeit pills. Dr. Korthuis will share availability and cost of adolescent inpatient addiction treatment programs in the U.S. and describe treatment services offered at U.S. inpatient addiction treatment programs. Posted 12/18/2023

The National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) recently hosted a webinar titled Addictions Research Meets Lived Experience: Lessons Learned, Opportunities and Challenges (October 30, 2023). Peer support services have expanded to a wide variety of health service settings, and evaluating the impact of peer services is an important addition to the research agenda. In this webinar, the presenters and panel members shared lessons learned in conducting trials with persons with lived experience -peers-participating as an integral component of the intervention. The goal of the webinar was to assist investigators in designing future studies with peers as interventionists. The agenda included an overview of the development of peer services in addiction treatment, a brief description of three research projects, and a panel discussion of peer supervision, self-care, scope of practice, fidelity, harm reduction approaches, and role induction for peers in research. Presenters: Keith Humphries, Kelly Barth, Steve Shoptaw, Nabila El-Bassel, Todd Korthuis Panel Members: Al Hasson (facilitator), Todd Korthuis, Louise Haynes, Pete Smith, Joanna Cooper Find the slides and recording here! Posted September 21, 2023

Join the NIDA HIV Research Program for the upcoming NIDA HIV Seminar with Sandra Springer, M.D., of Yale School of Medicine, 2022 recipient of the NIDA HIV Avant-Garde Award. Dr. Springer will present on “Integrating Addiction and HIV Prevention and Treatment for Everyone and Bringing it to Where They Live.” Dr. Springer is a Professor of Medicine at the Yale School of Medicine. Her research integrates aspects of substance use and infectious disease, with a focus on opioid use disorder treatment and the treatment and prevention of HIV among people with carceral experience. Learn more and register here!

CTN members are invited to join the next CTN Steering Committee Meeting, which will be held virtually on September 19, 2023 (2-4pm PT). The agenda will include final study reports for CTN-0134 (Buprenorphine-Precipitated Withdrawal Hotspots and Correlates) and CTN-0105 (Integrating Pharmacy-Based Prevention and Treatment of Opioid and Other Substance Use Disorders: A Survey of Pharmacists and Stakeholders), as well as a presentation from the Office of Research Training, Diversity, and Disparities on training opportunities to leverage the CTN Network (funding mechanisms and programs). Download the agenda here. Zoom connection information: Zoom Link: https://us02web.zoom.us/j/85039116127?pwd=WmczMDAyNGNYR2Q3dFRxNUFadUxtdz09Meeting ID: 850 3911 6127Passcode: 377366Phone: 301-715-8592One tap mobile: +13017158592,,85039116127#,,,,*377366#